Skip to main content
ADIM logo

ADIM — Investor Relations & Filings

Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,804 across all filing types
Latest filing 2017-06-09 Regulatory Filings
Country TW Taiwan
Listing TW 4142

About ADIM

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
106年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 國光生, providing information about loan balances and guarantee endorsements for the current and previous months. It contains tabular data on financial guarantees and loan amounts but does not include comprehensive financial statements, management discussion, or detailed report content. The document length is very short (616 characters), and it appears to be a regulatory disclosure or announcement rather than a full report. There is no indication of it being an annual or interim report, audit report, or earnings release. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement with financial data but not a full financial report or specific category filing.
2017-06-09 Chinese
106年5月營業收入
Interim / Quarterly Report Classification · 95% confidence The document is a revenue summary report for a specific month (May 2017, 民國106年05月) provided by a listed company (國光生). It contains monthly and cumulative revenue figures with percentage changes and explanations for revenue fluctuations. The document is short (792 characters) and primarily presents financial data for a partial period, not a full fiscal year. It is not an announcement of a report but actual financial data for a specific interim period. Therefore, it fits the definition of an Interim / Quarterly Report (IR), which includes substantive financial data for a period shorter than a full fiscal year. Q1 2017
2017-06-09 Chinese
105年度股利金額(股東會決議)
Notice of Dividend Amount Classification · 95% confidence The document text primarily contains detailed information about dividend distribution, including cash dividends, stock dividends, and related company policies. It includes tables and notes explaining dividend allocation and company regulations regarding dividend payments. There is no indication that this is a full annual or interim financial report, nor is it a brief announcement or a proxy solicitation. The content is focused on the announcement of dividend amounts and payment details to shareholders, which fits the definition of a Notice of Dividend Amount (DIV). The document length is under 5,000 characters and contains substantive dividend details, not just a reference or link to another report, so it is not a Report Publication Announcement (RPA). Therefore, the most appropriate classification is Notice of Dividend Amount (DIV).
2017-06-04 Chinese
106年5月變更登記
Share Issue/Capital Change Classification · 95% confidence The document is a brief disclosure from a listed company (國光生) providing details about its capital stock, including authorized capital, paid-in capital, and changes such as convertible bonds converted into shares. The content is focused on capital structure details and changes, without any financial statements or broader report context. The document length is short (808 characters), and it does not indicate it is an announcement of a report publication but rather a direct disclosure of capital information. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2017-06-02 Chinese
106年05月法人說明會簡報 — 414220170518E001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation including a review of 1Q2017 financial results, 2016 performance, and 2017 outlook, along with strategic growth plans and product pipeline information. It contains financial data such as revenue, profit and loss, balance sheet figures, and operational metrics. The presence of forward-looking statements, detailed financial tables, and strategic content aimed at investors indicates this is an investor-focused presentation. There is no indication that this is a full annual report (10-K) or an interim report (IR) with comprehensive financial statements, but rather a presentation summarizing quarterly results and outlook. The document is titled and structured as a presentation, with disclaimers typical of investor presentations. Therefore, the most appropriate classification is Investor Presentation (IP).
2017-05-18 Chinese
106年05月法人說明會簡報 — 414220170518M001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation dated May 2017, focusing on the company's 1Q2017 financial highlights, operational outlook for 2017, future growth strategies, and detailed business and product information. It includes financial data such as revenue, profit/loss, balance sheet items, and discusses clinical trials and market expansion. The content is structured as a presentation with slides, disclaimers, and forward-looking statements. There is no indication that this is a full annual or quarterly report filing, nor is it a brief earnings release or a regulatory announcement. The document matches the characteristics of an Investor Presentation (IP), which typically includes financials, strategy, and market position aimed at investors.
2017-05-18 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.